Compounds > irofulven
Page last updated: 2024-09-04

irofulven and Breast Neoplasms

irofulven has been researched along with Breast Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fitzsimmons, TD; Hammond, LA; Harrison, JM; Melendez, RF; Rowinsky, EK1
Calvo, F; Cvitkovic, E; Koeppel, F; Laar, ES; Larsen, AK; Lokiec, F; Poindessous, V; Raymond, E; Serova, M; Waters, SJ1
Chen, SF; Dexter, DL; Kelner, MJ; MacDonald, JR; Mangold, GL; McMorris, TC; Muscoplat, CC; Von Hoff, DD1
Herzig, MC; Johnson, AE; Liang, H; Woynarowska, B; Woynarowski, JM1

Other Studies

4 other study(ies) available for irofulven and Breast Neoplasms

ArticleYear
Acute retinal toxicity from the novel anti-tumor agent, Irofulven.
    Documenta ophthalmologica. Advances in ophthalmology, 2004, Volume: 108, Issue:3

    Topics: Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms; Electroretinography; Evoked Potentials, Visual; Female; Humans; Middle Aged; Retina; Retinal Diseases; Sesquiterpenes; Visual Fields

2004
Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
    Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:4

    Topics: Algorithms; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Genes, p53; HT29 Cells; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Sesquiterpenes; Tetrazolium Salts; Thiazoles

2006
Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S.
    Cancer research, 1997, Jan-15, Volume: 57, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Drug Screening Assays, Antitumor; Female; HT29 Cells; Humans; Leukemia P388; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Nude; Sesquiterpenes; Transplantation, Heterologous

1997
Irofulven induces apoptosis in breast cancer cells regardless of caspase-3 status.
    Breast cancer research and treatment, 2002, Volume: 71, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Breast Neoplasms; Caspase 3; Caspases; Cell Survival; DNA Fragmentation; Enzyme Activation; Female; Humans; Kinetics; Sesquiterpenes; Tumor Cells, Cultured

2002